INSUBCONTINENT EXCLUSIVE:
Jay Thakkar of Anand Rathi has a buy call on Biocon Ltd
with a target price of Rs 311.0
The current price of Biocon Ltd
Jay Thakkar recommended to keep a stoploss at Rs 296
Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 36126.00 Crore) operating in Pharmaceuticals
key Products/Revenue Segments include Other Operating Revenue which contributed Rs 229.40 Crore to Sales Value (7.95 % of Total Sales),
Waste which contributed Rs 15.10 Crore to Sales Value (0.52 % of Total Sales) and Sale of services which contributed Rs 1.00 Crore to Sales
Value (0.03 % of Total Sales)for the year ending 31-Mar-2019
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 1572.20 Crore, up 7.25 % from last quarter Sales of
Rs 1465.90 Crore and up 19.02 % from last year same quarter Sales of Rs 1321.00 Crore Company has reported net profit after tax of Rs 263.20
The company’s top management includes Dr.Arun Chandavarkar, Mr.Russel Walls, Mr.Mary Harney, Mr.M Damodaran, Mr.Kiran Mazumdar Shaw,
Mr.John Shaw, Mr.Daniel M Bradbury, Dr.Vijay Kuchroo, Dr.Jeremy Levin, Prof.Ravi Mazumdar
LLP as its auditoRs As on 30-09-2019, the company has a total of 1,200,000,000 shares outstanding.